A friend sent me an article by Dr. Sherri Tenpenny shortly before the COVID shots came out. I refused to read because I knew Sherri to be an “antivaxxer “. So I got the covid shots. God spared me. So I now do whatever I can to cause vaccine hesitancy. I just hosted a viewing of An Inconvenient Sudy at our church two weeks ago. Sherri was present for our Q&A session. Over 100 attendees. Wish it could have been more but many seeds were planted 🙏🏻🙏🏻🙏🏻
Yes Laura, God spared you for work you had no idea He would call you to do. And you ghosted Dr. T's article in the beginning. Glad that is in your rearview mirror! And so very glad you are alright after getting jabbed.
I've watched The Deposition twice -- since I have the utmost respect for attorney Siri's professionalism, passion and patience, and I experience satisfaction in watching the Father Of Vaccinology decline from smugness into nervous verbal shuffling when tirelessly confronted by Siri's probing inquiry. Interrogation like this exposes truth.
it was wonderful! i was saying that, after the Bret Weinstein Inside Rail interview, i hoped you'd make the real Big Time and suddenly, there you were on Rogan at last!! he's become a real convert and with his wide audience, your reach has expanded several million fold!
as a person who was fired from a 40 year career that was the center of my life simply because i wouldn't take a covid shot, i believe medical freedom is the pivotal subject of our time!
Loving the book! I appreciate the clarity. I LOVED The Real Anthony Fauci by our great RFK, Jr., but it was so dense (and perhaps I am a little myself in the other direction!) that I had to listen to it three times and am ready for a fourth. Aaron, your book is for the lay person and more focused for the parents who need to really grasp the nuts and bolts of how these vaccines were tested -- poorly! -- and what they do and do NOT do. Any parent can take this book and read a few paragraphs to the school admin and make these educstors understand why they oppose the unconstitutional vaccine mandates. And your book gives the information parents and adults SHOULD be getting from their hc provider but often don't. One GIANT step for man and woman and children kind.
I had to meet the dean of my daughters college to get a HPV vaccine exemption. This was 2007 or 08. The beginning of my journey into a rabbit hole that never had a bottom. I did get the exemption but it forced me to do quite a bit of homework before the meeting. From then until now the religion has got much worse, especially in NY. I have known this for almost twenty years. God Bless You Aaron.
Pfizer’s LNP distribution study showed the LNPs were everywhere in 15 minutes.
After 48 hours injection, the numbers in the ovaries and bone marrow and adrenals (a big deal) of the rats were going up and up. Then they killed the last rat at hour 48 - the LNPs were still coming out of the injection site, and were still flooding into organs when they decided to stop. The ONPATTRO mice were observed for a week in 2018.
The second test looked at the tissues - not good. Especially for a drug vehicle with nothing in it.
No wonder the data used to justify a worldwide drug rollout had to be FOIA requested.
They did the safety testing. The drug failed the test. They passed the drug.
They tested IV and IM. Below they talk about an IV rat study, cite fast liver clearance, and in the same paragraph switch studies and imply that the same finding holds for the Wistar rats who got it in the muscle. IV fast clearance was 9 days, so how long would have IM been? Injected directly into the bloodstream, they still found luciferase glowing after 9 days. a muscle shot would be longer. There is no ‘injection site’ when you go directly into the blood. That’s the ‘site’ - everywhere.
“The potential biodistribution of BNT162b2 was assessed using luciferase expression as a surrogate reporter. Protein expression was demonstrated at the site of injection and to a lesser extent, and more transiently, in the liver after BALB/c mice received an IM injection of RNA encoding luciferase in an LNP formulation like BNT162b2. Luciferase expression was identified at the injection site at 6 hours after injection and was not detected by 9 days.
Expression in the liver was also present at 6 hours after injection and was not detected by 48 hours after injection. These findings are supported by a quantitative biodistribution study in Wistar Han rats. After IM administration of a radiolabeled lipid marker and a luciferase modRNA in the same LNP formulation as BNT162b2 to rats, the percent of administered dose was greatest at the injection site. Outside of the injection site, total recovery of radioactivity was highest in the liver and much lower in the spleen, with very little recovery in the adrenal glands and ovaries.
They quote IV, and back it up with IM in 2 head to head sentences- deceptive?
“Expression in the liver was also present at 6 hours after injection and was not detected by 48 hours after injection. These findings are supported by a quantitative biodistribution study in Wistar Han rats”
supported by a 48 hour long experiment terminated when the numbers were still rising
Below is an expanded, human‑readable version of the serialized summary you asked to unflatten. I restored structure, clarified each key point, and grouped related items so you can use this directly in reports, FOIA requests, or to brief counsel and experts.
Key findings and context
Study identifiers185350, 38166, R-20-0072, PF-07302048, 20GR142, 20-0211, R-20-0085, R-20-0112, VR-VTR-10671.
Primary red flags
Early termination at 48 hours for the Wistar Han rat biodistribution study.
Rising counts in ovaries, bone marrow, and adrenals at the 48-hour termination point.
Conflation of IV and IM results in summary language that mixes species and assay types.
Mixing luciferase imaging and radiolabel assays without clarifying limits of each method.
Lack of longitudinal sampling beyond 48 hours.
Absence of reproductive and multigenerational endpoints.
Small sample sizes that are underpowered to detect rare but biologically important events.
Potential missing raw data and GLP notebooks that would be required for independent verification.
Route comparison summary
IV delivers immediate systemic exposure to highly perfused organs.
IM creates a local depot, drains via lymphatics, and produces slower systemic exposure that can prolong local expression and sustain low-level systemic presence.
IV and IM kinetics are not interchangeable and cannot be treated as equivalent evidence without explicit bridging data.
Timepoint and assay concerns
Timepoint issue
Mouse luciferase IM imaging is reported as cleared by nine days.
Rat radiolabel biodistribution sampling was performed from 0.25 to 48 hours and terminated at 48 hours.
Tissue counts were rising at 48 hours, leaving post-48-hour kinetics unknown and unreported.
Assays required to resolve uncertainty
Absolute nucleic acid quantification using ddPCR with LOD and LOQ.
qRT-PCR with standard curves and replicate runs.
In situ localization using RNAscope to identify cell types containing mRNA.
Protein detection by validated immunohistochemistry and orthogonal protein assays.
LNP component quantification by lipid mass spectrometry.
Radiolabeled or stable isotope tracking of LNP particles.
Integration detection using inverse PCR, targeted capture, and long-read genomic sequencing on germ cells and bone marrow.
Functional reproductive endpoints including estrous monitoring, sperm analysis, mating success, and F1 and F2 follow-up.
Recommended sampling schedule 6 hours, 24 hours, 48 hours, 7 days, 14 days, 28 days, 90 days, 180 days, plus biologically appropriate breeding windows and multigenerational follow-up.
Evidence to obtain and forensic verification
Raw materials to request immediately
Per-animal raw radioactivity tables and time series.
Raw Ct and ddPCR output files.
Assay validation files including standard curves and LOD/LOQ.
Full GLP study protocols, statistical analysis plans, and stopping-rule memos.
Study director signatures, GLP compliance statements, and chain-of-custody logs.
CRO lab notebooks, raw luciferase imaging files, and original image files.
PDF and file forensic checks
Compare page counts and table of contents across sources.
Extract and inspect metadata using pdfinfo and exiftool.
Check for incremental updates and redaction annotations using qpdf and PDF parsers.
Validate digital signatures and compare file hashes across independent repositories.
Look for missing attachments, blank content streams, or image-layer pages with no selectable text.
Legal strategy and evidentiary needs
Primary legal avenues
PREP Act willful misconduct exception requiring clear and convincing evidence of intentional concealment or conscious, flagrant disregard of known risk.
CICP administrative claim for countermeasure injuries, filed within the one-year deadline from vaccination.
Fraudulent concealment claims to toll statutes of limitation and obtain expedited discovery.
State consumer protection and fraud claims as parallel pressure points.
Evidentiary burden for willful misconduct
Internal communications or memos showing deliberate decision to terminate sampling to avoid detection.
Raw data demonstrating rising trends at termination.
Expert toxicologist declarations linking the study design choice to concealment of material safety signals.
Chain-of-custody and GLP documentation proving what was collected and what was withheld.
Immediate legal actions to preserve rights
File a CICP claim now and preserve medical records and vaccination documentation.
Submit FOIA requests to FDA for Module 2.6.4 and the specific study reports and raw data.
Retain counsel experienced in PREP Act litigation and in obtaining expedited discovery.
Prepare a fraudulent-concealment pleading to toll limitations and compel production.
Investigation plan and next steps
Short-term tasks
FOIA for Module 2.6.4 and Studies 185350 and 38166 requesting unredacted GLP reports and raw data.
Preserve evidence by downloading and hashing all public copies and documenting sources.
Engage experts including a regulatory toxicologist and reproductive toxicologist to draft a short declaration comparing the study to industry norms.
Run forensic checks on any downloaded PDFs to detect redaction or truncation.
Medium-term strategy
Use expert declarations and FOIA results to support a fraudulent-concealment pleading and seek expedited discovery.
If discovery yields internal documents showing concealment, pursue PREP Act willful-misconduct litigation and parallel regulatory petitions.
Consider commissioning an independent GLP replication only after funding or discovery provides necessary materials.
Industry benchmark note Most peer-reviewed LNP biodistribution programs sample beyond 48 hours and use multi-modal assays to characterize persistence and reproductive risk. A 48-hour-only terminal timepoint is atypical for questions about persistence or germline exposure and therefore requires strong justification and full disclosure of raw data.
GREAT interview! Thank you Aaron and all of your office personnel for EVERYTHING that you have done and continue to do for people that you don't even know. #YOUROCKWARRIOR
Aaron - I listened to all of it. Bravo!
A friend sent me an article by Dr. Sherri Tenpenny shortly before the COVID shots came out. I refused to read because I knew Sherri to be an “antivaxxer “. So I got the covid shots. God spared me. So I now do whatever I can to cause vaccine hesitancy. I just hosted a viewing of An Inconvenient Sudy at our church two weeks ago. Sherri was present for our Q&A session. Over 100 attendees. Wish it could have been more but many seeds were planted 🙏🏻🙏🏻🙏🏻
Yes Laura, God spared you for work you had no idea He would call you to do. And you ghosted Dr. T's article in the beginning. Glad that is in your rearview mirror! And so very glad you are alright after getting jabbed.
Amen, Ageandreams 🥰🙏🏻
Excellent interview and book! Thank you for your courage and leadership!!
🥰 Brought to me by the Holy Spirit BobbieJo. 🙏🏻
Humility is a beautiful thing. May more minds open like yours. Thank you
I pray for that every day Eve. 🙏🏻🙏🏻🙏🏻
i applaud you!
Blessings Carolyn. 😘❤️🙏🏻
You're doing an amazing job Aaron!!! God bless you and your family.
I've watched The Deposition twice -- since I have the utmost respect for attorney Siri's professionalism, passion and patience, and I experience satisfaction in watching the Father Of Vaccinology decline from smugness into nervous verbal shuffling when tirelessly confronted by Siri's probing inquiry. Interrogation like this exposes truth.
The deposition is a priceless gift! And it took place on my birthday. That brings me joy.
Smug is a perfect descriptor got the guy!
Psychopath is better
That too!
You're the man Aaron
You are doing excellent work. Huge thanks from an autism Dad here.
Excellent interview.
it was wonderful! i was saying that, after the Bret Weinstein Inside Rail interview, i hoped you'd make the real Big Time and suddenly, there you were on Rogan at last!! he's become a real convert and with his wide audience, your reach has expanded several million fold!
as a person who was fired from a 40 year career that was the center of my life simply because i wouldn't take a covid shot, i believe medical freedom is the pivotal subject of our time!
Loving the book! I appreciate the clarity. I LOVED The Real Anthony Fauci by our great RFK, Jr., but it was so dense (and perhaps I am a little myself in the other direction!) that I had to listen to it three times and am ready for a fourth. Aaron, your book is for the lay person and more focused for the parents who need to really grasp the nuts and bolts of how these vaccines were tested -- poorly! -- and what they do and do NOT do. Any parent can take this book and read a few paragraphs to the school admin and make these educstors understand why they oppose the unconstitutional vaccine mandates. And your book gives the information parents and adults SHOULD be getting from their hc provider but often don't. One GIANT step for man and woman and children kind.
Loved the book!
Loved the video!
People need to venture out of their bubbles. If you don't talk to people, you're ignorant. I don't care what school you went to or who you know.
I had to meet the dean of my daughters college to get a HPV vaccine exemption. This was 2007 or 08. The beginning of my journey into a rabbit hole that never had a bottom. I did get the exemption but it forced me to do quite a bit of homework before the meeting. From then until now the religion has got much worse, especially in NY. I have known this for almost twenty years. God Bless You Aaron.
Well done!! Thank you.
Executive Summary: you must read the link for full story
https://badprotein.substack.com/p/vger
Pfizer’s LNP distribution study showed the LNPs were everywhere in 15 minutes.
After 48 hours injection, the numbers in the ovaries and bone marrow and adrenals (a big deal) of the rats were going up and up. Then they killed the last rat at hour 48 - the LNPs were still coming out of the injection site, and were still flooding into organs when they decided to stop. The ONPATTRO mice were observed for a week in 2018.
The second test looked at the tissues - not good. Especially for a drug vehicle with nothing in it.
No wonder the data used to justify a worldwide drug rollout had to be FOIA requested.
They did the safety testing. The drug failed the test. They passed the drug.
https://badprotein.substack.com/p/vger
They tested IV and IM. Below they talk about an IV rat study, cite fast liver clearance, and in the same paragraph switch studies and imply that the same finding holds for the Wistar rats who got it in the muscle. IV fast clearance was 9 days, so how long would have IM been? Injected directly into the bloodstream, they still found luciferase glowing after 9 days. a muscle shot would be longer. There is no ‘injection site’ when you go directly into the blood. That’s the ‘site’ - everywhere.
“The potential biodistribution of BNT162b2 was assessed using luciferase expression as a surrogate reporter. Protein expression was demonstrated at the site of injection and to a lesser extent, and more transiently, in the liver after BALB/c mice received an IM injection of RNA encoding luciferase in an LNP formulation like BNT162b2. Luciferase expression was identified at the injection site at 6 hours after injection and was not detected by 9 days.
Expression in the liver was also present at 6 hours after injection and was not detected by 48 hours after injection. These findings are supported by a quantitative biodistribution study in Wistar Han rats. After IM administration of a radiolabeled lipid marker and a luciferase modRNA in the same LNP formulation as BNT162b2 to rats, the percent of administered dose was greatest at the injection site. Outside of the injection site, total recovery of radioactivity was highest in the liver and much lower in the spleen, with very little recovery in the adrenal glands and ovaries.
They quote IV, and back it up with IM in 2 head to head sentences- deceptive?
“Expression in the liver was also present at 6 hours after injection and was not detected by 48 hours after injection. These findings are supported by a quantitative biodistribution study in Wistar Han rats”
supported by a 48 hour long experiment terminated when the numbers were still rising
Overview
Below is an expanded, human‑readable version of the serialized summary you asked to unflatten. I restored structure, clarified each key point, and grouped related items so you can use this directly in reports, FOIA requests, or to brief counsel and experts.
Key findings and context
Study identifiers185350, 38166, R-20-0072, PF-07302048, 20GR142, 20-0211, R-20-0085, R-20-0112, VR-VTR-10671.
Primary red flags
Early termination at 48 hours for the Wistar Han rat biodistribution study.
Rising counts in ovaries, bone marrow, and adrenals at the 48-hour termination point.
Conflation of IV and IM results in summary language that mixes species and assay types.
Mixing luciferase imaging and radiolabel assays without clarifying limits of each method.
Lack of longitudinal sampling beyond 48 hours.
Absence of reproductive and multigenerational endpoints.
Small sample sizes that are underpowered to detect rare but biologically important events.
Potential missing raw data and GLP notebooks that would be required for independent verification.
Route comparison summary
IV delivers immediate systemic exposure to highly perfused organs.
IM creates a local depot, drains via lymphatics, and produces slower systemic exposure that can prolong local expression and sustain low-level systemic presence.
IV and IM kinetics are not interchangeable and cannot be treated as equivalent evidence without explicit bridging data.
Timepoint and assay concerns
Timepoint issue
Mouse luciferase IM imaging is reported as cleared by nine days.
Rat radiolabel biodistribution sampling was performed from 0.25 to 48 hours and terminated at 48 hours.
Tissue counts were rising at 48 hours, leaving post-48-hour kinetics unknown and unreported.
Assays required to resolve uncertainty
Absolute nucleic acid quantification using ddPCR with LOD and LOQ.
qRT-PCR with standard curves and replicate runs.
In situ localization using RNAscope to identify cell types containing mRNA.
Protein detection by validated immunohistochemistry and orthogonal protein assays.
LNP component quantification by lipid mass spectrometry.
Radiolabeled or stable isotope tracking of LNP particles.
Integration detection using inverse PCR, targeted capture, and long-read genomic sequencing on germ cells and bone marrow.
Functional reproductive endpoints including estrous monitoring, sperm analysis, mating success, and F1 and F2 follow-up.
Recommended sampling schedule 6 hours, 24 hours, 48 hours, 7 days, 14 days, 28 days, 90 days, 180 days, plus biologically appropriate breeding windows and multigenerational follow-up.
Evidence to obtain and forensic verification
Raw materials to request immediately
Per-animal raw radioactivity tables and time series.
Raw Ct and ddPCR output files.
Assay validation files including standard curves and LOD/LOQ.
Full GLP study protocols, statistical analysis plans, and stopping-rule memos.
Study director signatures, GLP compliance statements, and chain-of-custody logs.
CRO lab notebooks, raw luciferase imaging files, and original image files.
PDF and file forensic checks
Compare page counts and table of contents across sources.
Extract and inspect metadata using pdfinfo and exiftool.
Check for incremental updates and redaction annotations using qpdf and PDF parsers.
Validate digital signatures and compare file hashes across independent repositories.
Look for missing attachments, blank content streams, or image-layer pages with no selectable text.
Legal strategy and evidentiary needs
Primary legal avenues
PREP Act willful misconduct exception requiring clear and convincing evidence of intentional concealment or conscious, flagrant disregard of known risk.
CICP administrative claim for countermeasure injuries, filed within the one-year deadline from vaccination.
Fraudulent concealment claims to toll statutes of limitation and obtain expedited discovery.
State consumer protection and fraud claims as parallel pressure points.
Evidentiary burden for willful misconduct
Internal communications or memos showing deliberate decision to terminate sampling to avoid detection.
Raw data demonstrating rising trends at termination.
Expert toxicologist declarations linking the study design choice to concealment of material safety signals.
Chain-of-custody and GLP documentation proving what was collected and what was withheld.
Immediate legal actions to preserve rights
File a CICP claim now and preserve medical records and vaccination documentation.
Submit FOIA requests to FDA for Module 2.6.4 and the specific study reports and raw data.
Retain counsel experienced in PREP Act litigation and in obtaining expedited discovery.
Prepare a fraudulent-concealment pleading to toll limitations and compel production.
Investigation plan and next steps
Short-term tasks
FOIA for Module 2.6.4 and Studies 185350 and 38166 requesting unredacted GLP reports and raw data.
Preserve evidence by downloading and hashing all public copies and documenting sources.
Engage experts including a regulatory toxicologist and reproductive toxicologist to draft a short declaration comparing the study to industry norms.
Run forensic checks on any downloaded PDFs to detect redaction or truncation.
Medium-term strategy
Use expert declarations and FOIA results to support a fraudulent-concealment pleading and seek expedited discovery.
If discovery yields internal documents showing concealment, pursue PREP Act willful-misconduct litigation and parallel regulatory petitions.
Consider commissioning an independent GLP replication only after funding or discovery provides necessary materials.
Industry benchmark note Most peer-reviewed LNP biodistribution programs sample beyond 48 hours and use multi-modal assays to characterize persistence and reproductive risk. A 48-hour-only terminal timepoint is atypical for questions about persistence or germline exposure and therefore requires strong justification and full disclosure of raw data.
SUMMARY_SERIALIZED_V1 VERSION:1 SOURCE:condensed_chat_transcript FORMAT:ASCII_SERIAL_KEYVALUE
STUDY_IDS:185350|38166|R-20-0072|PF-07302048|20GR142|20-0211|R-20-0085|R-20-0112|VR-VTR-10671
RED_FLAGS:early_termination_at_48h|rising_counts_in_ovaries_bone_marrow_adrenals_at_termination|conflation_of_IV_and_IM_results|mixing_luciferase_and_radiolabel_assays_in_summary|lack_of_longitudinal_sampling|absence_of_reproductive/multigenerational_endpoints|small_sample_size_underpowered_for_rare_events|missing_raw_data_and_GL P_notebooks_possible
ROUTE_COMPARISON:IV=immediate_systemic_distribution_highly_perfused_organs|IM=local_depot+lymphatic_drainage+slower_systemic_exposure|IM_can_prolong_local_expression_and_sustain_low_level_systemic_exposure|IV_and_IM_kinetics_not_interchangeable
KEY_QUOTED_PARAGRAPH_SOURCE:Module_2.6.4_Pharmacokinetics_Written_Summary|Wistar_Han_Study_185350_radiolabel_report|R-20-0072_mouse_luciferase_report
TIMEPOINT_ISSUE:reported_mouse_IM_luciferase_cleared_by_9_days|rat_radiolabel_sampling_0.25-48h_terminated_at_48h|observed_rising_tissue_counts_at_48h→unknown_post-48h_kinetics
ASSAYS_REQUIRED_FOR_CLARITY:ddPCR_absolute_quantification_with_LOD_LOQ|qRT-PCR_with_standard_curves|RNAscope_in_situ_localization|IHC_for_translated_protein|lipid_mass_spectrometry_for_LNP_components|radiolabeled_or_isotope_tracking_of_LNP|inverse_PCR_and_targeted_capture_for_integration|long-read_genomic_sequencing_on_germ_cells|functional_reproductive_endpoints(mating,F1,F2)
TIMEPOINTS_RECOMMENDED:6h|24h|48h|7d|14d|28d|90d|180d|breeding_windows_and_F1_F2_followup
EVIDENCE_TO_OBTAIN:per-animal_raw_radioactivity_tables|raw_Ct/ddPCR_values|assay_validation_files(standard_curves,LOD/LOQ)|GLP_study_protocol_and_SAP|study_director_signatures|lab_notebooks_chain_of_custody|DSMB_minutes_and_internal_memos_on_termination|CRO_identity_and_contracts|luciferase_imaging_files_and_raw_images
FORENSIC_PDF_METADATA_CHECKS:compare_page_count_and_expected_TOC|pdfinfo_and_exiftool_metadata|qpdf_show_xref_for_incremental_updates|check_for_redaction_annotations(/Redact,/Redaction)|validate_digital_signatures|compare_hashes_across_sources|look_for_missing_attachments_or_blank_content_streams
LEGAL_GROUNDS_RANKED:PREP_Act_willful_misconduct_exception(clear_convincing_evidence_of_intent_or_conscious_disregard)|CICP_claim(compelling_reliable_valid_medical_scientific_evidence;1-year_deadline)|fraudulent_concealment(tolling_and_discovery_leverage)|state_consumer_protection_and_fraud_claims|ordinary_negligence/product_liability(low_if_PREP_applies)
EVIDENTIARY_BURDEN_WILLFUL:internal_documents_showing_deliberate_cutoff_or_concealment|emails/DSMB_memos_explaining_termination|raw_data_showing_rising_trends|expert_toxicologist_declaration_linking_design_to_risk|chain_of_custody_and_GL P_compliance_docs
IMMEDIATE_ACTIONS:FILE_CICP_CLAIM_NOW|FOIA_request_to_FDA_for_Module_2.6.4_and_Studies_185350_38166_R-20-0072_PF-07302048_20GR142|preserve_all_files_and_metadata|retain_PREP_experienced_federal_counsel|retain_regulatory_toxicologist_for_expert_opinion|compute_SHA256_hashes_of_downloads
FOIA_REQUEST_TARGETS:Module_2.6.4_Pharmacokinetics_Written_Summary|Study_185350_full_GL P_report_and_raw_tables|Study_38166_full_GL P_report|R-20-0072_luciferase_raw_images|PF-07302048_PK_report|GLP_notebooks|study_protocols_and_stopping_rule_memos|CRO_lab_notebooks|assay_validation_files
INVESTIGATION_STRATEGY:1)obtain_unredacted_GL P_reports_via_FOIA_or_discovery 2)expert_review_compare_timepoints_and_assays_to_industry_norms 3)if_fraudulent_concealment_evidence→file_tolling_pleading_and_seek_expedited_discovery 4)commission_independent_replication_if_funded_or_after_discovery 5)publish_pre-registered_protocol_and_results_to_force_transparency
INDUSTRY_BENCHMARKS:typical_LNP_biodistribution_studies_sample_days_to_weeks_and_use_multi-modal_assays|48h_only_design_is_atypICAL_for_germline_or_persistence_questions
RISKS_AND_LIMITS:PREP_immunity_blocks_most_torts_absent_willful_misconduct|CICP_awards_limited_and_administrative_delay_possible|FOIA_may_return_redacted_materials|need_extraordinary_documentary_evidence_for_willful_misconduct
COMMUNICATION_TACTICS:document_and_preserve_chain_of_custody|compare_multiple_public_copies_for_redaction|use_expert_declarations_to_frame_discovery_requests|leverage_fraudulent_concealment_to_toll_statute_and_force_production
OUTPUT_FORMAT_NOTES:serialized_keyvalue_pairs_pipe_separated_values|keys_uppercase|values_compact_tokens_no_newline_lists
END_OF_MESSAGE
And now they're trying to give immunity to herbicides and pesticides. Yeah, anything that's dangerous, let's give them liability!
Love your discussion on personal liberty and medical freedom!! I’m a single issue voter—MEDICAL FREEDOM!
I am, too, but my issue is FREEDOM, period!
GREAT interview! Thank you Aaron and all of your office personnel for EVERYTHING that you have done and continue to do for people that you don't even know. #YOUROCKWARRIOR
Thank you, thank you endlessly for your work!